UPB compared with CMPX: revenue, margins and what each company keeps, and the suppliers and customers both name

UPBUpstream Bio, Inc.

Mkt capRevenueRevenue

CMPXCompass Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

UPBUpstream Bio, Inc.

CMPXCompass Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

UPBUpstream Bio, Inc.

3.41▲+4.28%· post 3.40

Mkt cap$186.1MRevenue$773,000Q2 FY26Revenue$3MFY25

CMPXCompass Therapeutics, Inc.

0.79▲+3.85%· post 0.79

ClosedOct 30 '26

Mkt cap$141.6MRevenue$850,000Q2 FY24Revenue—

Compare

ClosedOct 30 '26

UPBUpstream Bio, Inc.

CMPXCompass Therapeutics, Inc.

3.41▲+4.28%post 3.40

Price

0.79▲+3.85%post 0.79

$186.1M

Mkt cap

$141.6M

Q2 FY26$773,000

Revenue

$850,000Q2 FY24

FY25$3M

Revenue

—

UPB3.41▲+4.28%vsCMPX0.79▲+3.85%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

UPB, solidCMPX, dashed

Supply-chain overlap

Revenue flow

UPB: latest quarter is a loss; flow not drawable. CMPX: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only UPB 5

REGNRegeneron Pharmaceuticalssupplier

—Astellas Pharmaunlistedsupplier

—Lonza Salesunlistedsupplier

—Wuxi Biologics (Hong Kong)unlistedsupplier

1 more · UPB chain ›

Shared 0

No shared counterparties.

Only CMPX 5

—ABL Biounlistedsupplier

—Adimabunlistedsupplier

—B. Riley Securitiesunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Elpiscience Biopharmaceuticals

unlistedsupplier

1 more · CMPX chain ›